*ST Shuangcheng announced that it recently received a notice from the US Food and Drug Administration. The company's application for bortezomib for injectable use to the US FDA has been approved by the US FDA.

*ST Shuangcheng announced that it recently received a notice from the US Food and Drug Administration. The company's application for bortezomib for injectable use to the US FDA has been approved by the US FDA.